Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Lotte Chemical Titan Tbk. (FPNI) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance

Lotte Chemical Titan Tbk.Trade
Organon Pharma Indonesia Tbk.Trade

Price performance (Past 24H)

Key statistics

Lotte Chemical Titan Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Lotte Chemical Titan Tbk. trades at Rp545 (market cap 3.15T, 3.73M 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Lotte Chemical Titan Tbk. is far larger — about 30.2× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.

FPNISCPI
Market Cap
3.15T104.4B
Volume
3.73M
Lot
37.31K
Turnover
2.02B
Average Price
541.28
Value
2.02B
Indicative Equilibrium Price
545
Indicative Equilibrium Volume
643

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

FPNI
View details
SCPI
View details

About Lotte Chemical Titan Tbk.

PT. Lotte Chemical Titan Tbk. (the Company) was established in the Republic of Indonesia under the name of P.T. Indofatra Plastik Industri based on Notarial Deed No. 19 of Rukmasanti Hardjasatya, S.H., dated December 9, 1987. Subsequently, its name was changed to P.T. Fatrapolindo Nusa Industri based on Notarial Deed No. 53 dated July 18, 1988 of the same notary. The Company conduct in Bi-axially Oriented Polypropylene/ BOPP Film industry. Start the commercial operation on 1990 by one line production. Now, the corporate have load capacity 20.000 ton/year.

Read more on FPNI

About Organon Pharma Indonesia Tbk.

PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.

Read more on SCPI